261 |
Probiotic Strain of Lactobacillus Reuteri Exhibiting Anti-Helicobacter Activity, a Probiotic or Biotherapeutic Product Comprising Said Strain, and the Use Thereof |
US14913514 |
2014-08-21 |
US20160279180A1 |
2016-09-29 |
Baltasar Mayo Pérez; Susana Delgado Palacio |
The invention relates to a new strain of Lactobacillus reuteri isolated from the human stomach, exhibiting antioxidant and antimicrobial activity, in particular an anti-Helicobacter effect, considerable resistance to the conditions of the gastric ecosystem, and the capacity to adhere to the epithelium. The invention also relates to a probiotic or biotherapeutic product which contains the strain of L. reuteri and is suitable for use in the treatment or prophylaxis of gastric diseases caused by the Helicobacter pylori bacteria, in order to prevent the secondary effects associated with conventional antibiotic treatments. |
262 |
COMPOSITION AND USE OF LACTOBACILLUS REUTERI GMNL-263 IN DECREASING BLOOD LIPID LEVELS |
US14618188 |
2015-02-10 |
US20160095889A1 |
2016-04-07 |
YI-HSING CHEN; YA-HUI CHEN; TZU-CHI LOU; TING-YUN SHEN |
A use of a Lactobacillus reuteri GMNL-263 in decreasing blood lipid levels is disclosed. Lactobacillus reuteri GMNL-263 (accession No.: CCTCC M 209263) specifically inhibits gene expression related to pro-inflammatory factor and lipid synthesis and promotes gene expression related to cholesterol metabolism. Lactobacillus reuteri GMNL-263 is utilized to produce a composition for decreasing blood lipid levels, thereby achieving the aim of hyperlipidemia treatment. |
263 |
Composition and method of Lactobacillus reuteri GMNL-89 in treating type 2 diabetes |
US14200162 |
2014-03-07 |
US09301983B2 |
2016-04-05 |
Hui-Yu Huang; Yi-Hsing Chen; Feng-Ching Hsieh |
Present invention features a novel use of Lactobacillus for treating type 2 diabetes, wherein the Lactobacillus is Lactobacillus reuteri GMNL-89 with the deposition numbers of BCRC 910340 and CCTCC M 207154 and comprises of live, dead bacteria or supernatant of the bacterial culture(s) and a pharmaceutically acceptable vehicle. The invention also discloses the efficacies of the indicated Lactobacillus strain including anti-oxidative enzyme activity, anti-inflammation, reduction of blood glucose level, reduction of triglycerides, reduction of total cholesterol, reduction of LDL, increase of HDL and improve insulin utilization. |
264 |
COMPOSITION COMPRISING LACTOBACILLUS AND A CARRIER |
US14766591 |
2014-02-05 |
US20150374764A1 |
2015-12-31 |
Karen T. ROBINS; Judith MAZOTTI; Kurt GASSER |
Subject of the invention is a food composition comprising Lactobacillus, or a Lactobacillus preparation, which comprises Lactobacillus cell walls, cell wall fragments and/or cell wall constituents, which is capable of aggregating Helicobacter pylori under physiological conditions, and a carrier, wherein the carrier comprises skim milk. Subject of the invention are also methods for producing such food compositions and uses thereof. |
265 |
COMPOSITIONS AND METHODS FOR REDUCED CARBOHYDRATES AND INCREASED ERYTHRITOL IN BEVERAGES |
US14436588 |
2013-10-17 |
US20150320099A1 |
2015-11-12 |
Jeroen HUGENHOLTZ; Thilo TRACHOTTA; Martijn BEKKER; Christel CARRIGUES |
The present invention provides novel compositions and methods for naturally decreasing carbohydrates and calories, while increasing erythritol, in beverages. The method includes fermenting beverages, such as fruit juices with a microorganism capable of metabolizing sugars into sugar alcohol(s) such as erythritol, to produce a fermented beverage having reduced carbohydrates, and therefore reduced calories, and increased erythritol as compared to an unfermented equivalent beverage. |
266 |
Selection and Use of Lactic Acid Bacteria Preventing Bone Loss in Mammals |
US14405496 |
2013-06-04 |
US20150150917A1 |
2015-06-04 |
Eamonn Connolly; Robert Allen Britton, II; Laura Rae McCabe |
The present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The selection method is based on the strain's capability of reestablishing an altered microbial community to normal and/or harboring at least one of four specific SNPs. |
267 |
EXTRUDED NON-REPLICATING PROBIOTIC MICRO-ORGANISMS AND THEIR HEALTH BENEFITS |
US14541434 |
2014-11-14 |
US20150072033A1 |
2015-03-12 |
Annick Mercenier; Antoine Wermeille; Audrey Demont; Guenolee Prioult |
The present invention generally relates to the field of pro biotic micro-organisms, in particular to the field of non-replicating probiotic micro-organisms. Embodiments of the present invention relate to compositions comprising probiotic microorganisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system. |
268 |
Anti-obesity agent and anti-obesity food |
US13154185 |
2011-06-06 |
US08637001B2 |
2014-01-28 |
Hidetoshi Morita; Toshio Masaoka; Takehito Suzuki |
An anti-obesity agent containing, as an active ingredient, a microorganism which belongs to the species Lactobacillus reuteri and is capable of producing lipases having the amino acid sequences respectively depicted in SEQ ID NO: 1, 3 or 5 or amino acid sequences having deletion, substitution or addition of one or more amino acids in the amino acid sequences respectively depicted in SEQ ID NO: 1, 3 or 5. The anti-obesity agent enables a patient to take a normal meal yet preventing the absorption of a fat into the body which is the primary cause of obesity. |
269 |
Dairy composition with probiotics and anti-microbial system |
US13709334 |
2012-12-10 |
US08617625B2 |
2013-12-31 |
Gary Francis Smith; Alice Shen Cha; Zuoxing Zheng; Michael Gerard Roman; Benjamin Emanuel Dias |
Dairy compositions are provided having a high pH, of about 4.8 to about 6.2, comprising desirable probiotic cultures as well as an anti-microbial system for inhibiting undesirable pathogenic and/or spoilage microbial growth without significantly reducing the beneficial effect of the probiotic cultures. |
270 |
Complete liquid nutrition for children at the age of 1-10 years comprising probiotics |
US13319961 |
2010-05-11 |
US08603492B2 |
2013-12-10 |
Annick Mercenier; Sophie Nutten; Guenolee Prioult |
The present invention relates to the field of nutrition for children. In particular, the present invention relates to the nutritional compositions intended for children with an impaired function of the gastro-intestinal tract. One embodiment of the present invention relates to a nutritional composition to be administered to children with an impaired function of the gastrointestinal tract comprising probiotic micro-organisms. The probiotic micro-organisms may be non-replicating, for example bioactive heat treated probiotic micro-organisms. |
271 |
BIFIDOBACTERIUM LONGUM NCC2705 (CNCM I-2618) AND IMMUNE DISORDERS |
US13901176 |
2013-05-23 |
US20130260440A1 |
2013-10-03 |
Valerie Petit; Clara Garcia-Rodenas; Monique Julita; Guenolee Prioult; Annick Mercenier; Sophie Nutten |
The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of B. longum NCC2705 (deposit number CNCM 1-2618) for use in the treatment or prevention of disorders related to the immune system including infections. |
272 |
Increased folate production levels in Lactobacillus fermenting melon juice |
US12811782 |
2008-12-05 |
US08524297B2 |
2013-09-03 |
Henderikus Bernardus Albertus Wegkamp; Filipe Branco dos Santos; Eilt Johannes Smid; Jeroen Hugenholtz |
The invention relates to the field of food, feed and food supplements comprising high folate levels, whereby the folate is produced by fermentation of Lactobacillus strains on melon fruit extract. Methods for increasing folate production of Lactobacillus strains are also provided. |
273 |
Dairy Composition With Probiotics And Anti-Microbial System |
US13709334 |
2012-12-10 |
US20130164410A1 |
2013-06-27 |
Gary Francis Smith; Alice Shen Cha; Zuoxing Zheng; Michael Gerard Roman; Benjamin Emanuel Dias |
Dairy compositions are provided having a high pH, of about 4.8 to about 6.2, comprising desirable probiotic cultures as well as an anti-microbial system for inhibiting undesirable pathogenic and/or spoilage microbial growth without significantly reducing the beneficial effect of the probiotic cultures. |
274 |
GROWING UP MILKS CONTAINING PROBIOTIC MICRO-ORGANISMS |
US13319477 |
2010-05-11 |
US20120269789A1 |
2012-10-25 |
Annick Mercenier; Sophie Nutten; Guenolee Prioult |
The present invention relates to the field of nutrition for infants and young children. In particular, the present invention relates to growing-up milks comprising probiotic micro-organisms to be administered to infants and young children older than 10 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. |
275 |
ORAL NUTRITIONAL SUPPLEMENT FOR CHILDREN COMPRISING PROBIOTICS |
US13319943 |
2010-05-11 |
US20120189598A1 |
2012-07-26 |
Annick Mercenier; Sophie Nutten; Guenolee Prioult |
The present invention relates to the field of nutrition for children. In particular, the present invention relates to the field of oral supplements. One embodiment of the present invention relates to the field of oral supplements comprising probiotics and/or bioactive non-replicating probiotics, for example heat treated probiotics. |
276 |
NUTRITIONALLY BALANCED STANDARD TUBE FEEDING FORMULA CONTAINING PROBIOTICS |
US13319947 |
2010-05-11 |
US20120141444A1 |
2012-06-07 |
Annick Mercenier; Sophie Nutten; Guenolee Prioult |
The present invention relates to the field of enteral nutrition to be administered via tube feeding. In particular, the present invention provides tube feeding formulas for complete nutrition comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example. |
277 |
INFANT FEEDING FORMULAS COMPRISING PROBIOTIC MICRO-ORGANISMS |
US13319627 |
2010-05-11 |
US20120128726A1 |
2012-05-24 |
Annick Mercenier; Sophie Nutten; Guenolee Prioult |
The present invention relates to the field of infant nutrition. In particular, the present invention relates to infant feeding formulas comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. |
278 |
BREAKFAST CEREALS CONTAINING PROBIOTIC MICRO ORGANISMS |
US13319965 |
2010-05-11 |
US20120121685A1 |
2012-05-17 |
Annick Mercenier; Sophie Nutten; Guenolee Prioult |
The present invention relates to the field of nutrition. In particular, the present invention relates to a breakfast cereal composition comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. |
279 |
SPECIALIZED NUTRITIONAL FORMULA FOR ADULT PATIENTS WITH GASTROINTESTINAL INTOLERANCE CONTAINING PROBIOTICS |
US13319949 |
2010-05-11 |
US20120121563A1 |
2012-05-17 |
Annick Mercenier; Sophie Nutten; Guenolee Prioult |
The present invention relates to the field of nutrition for adults. In particular, the present invention relates to the nutritional compositions intended for adults with an impaired function of the gastro-intestinal tract. One embodiment of the present invention relates to a nutritional composition to be administered to adults with an impaired function of the gastrointestinal tract comprising probiotic micro-organisms. The probiotic micro-organisms may be non-replicating, for example bioactive heat treated probiotic micro-organisms. |
280 |
INFANT AND YOUNG CHILDREN FEEDING FORMULA COMPRISING PROBIOTICS FOR INFANTS AND YOUNG CHILDREN |
US13319638 |
2010-05-11 |
US20120064051A1 |
2012-03-15 |
Annick Mercenier; Sophie Nutten; Guenolee Prioult |
The present invention relates to the field of infant and young children nutrition. In particular, the present invention relates to infant and young children feeding formulas comprising probiotic micro-organisms to be administered to infants and young children older than 6 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. |